Braxia Scientific Corp Stock Debt To Equity
| BRAXF Stock | USD 0 0 33.33% |
Braxia Scientific Corp fundamentals help investors to digest information that contributes to Braxia Scientific's financial success or failures. It also enables traders to predict the movement of Braxia Pink Sheet. The fundamental analysis module provides a way to measure Braxia Scientific's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Braxia Scientific pink sheet.
Braxia |
Braxia Scientific Corp Company Debt To Equity Analysis
Braxia Scientific's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current Braxia Scientific Debt To Equity | 0.03 % |
Most of Braxia Scientific's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Braxia Scientific Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
According to the company disclosure, Braxia Scientific Corp has a Debt To Equity of 0.026%. This is 99.95% lower than that of the Healthcare sector and 99.87% lower than that of the Biotechnology industry. The debt to equity for all United States stocks is 99.95% higher than that of the company.
Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
| All Next | Launch Module |
Braxia Fundamentals
| Return On Equity | -1.02 | |||
| Return On Asset | -0.28 | |||
| Operating Margin | (4.42) % | |||
| Current Valuation | 4.7 M | |||
| Shares Outstanding | 240.72 M | |||
| Shares Owned By Insiders | 11.48 % | |||
| Shares Owned By Institutions | 0.34 % | |||
| Price To Book | 0.91 X | |||
| Price To Sales | 4.45 X | |||
| Revenue | 1.49 M | |||
| Gross Profit | 246.87 K | |||
| EBITDA | (6.91 M) | |||
| Net Income | (12.13 M) | |||
| Cash And Equivalents | 7.68 M | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 52.55 K | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 3.48 X | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (4.52 M) | |||
| Earnings Per Share | (0.04) X | |||
| Beta | 1.59 | |||
| Market Capitalization | 13.03 M | |||
| Total Asset | 11.63 M | |||
| Net Asset | 11.63 M |
About Braxia Scientific Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Braxia Scientific Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Braxia Scientific using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Braxia Scientific Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Braxia Pink Sheet
Braxia Scientific financial ratios help investors to determine whether Braxia Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Braxia with respect to the benefits of owning Braxia Scientific security.